An Exome Sequencing Study to Assess the Role of Rare Genetic Variation in Pulmonary Fibrosis-Reference-Cited by-同舟云学术

An Exome Sequencing Study to Assess the Role of Rare Genetic Variation in Pulmonary Fibrosis

Published:2017-07 Issue:1 Volume:196 Page:82-93
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Petrovski Slavé¹²^ORCID,Todd Jamie L.³⁴,Durheim Michael T.³⁴^ORCID,Wang Quanli¹,Chien Jason W.⁵^ORCID,Kelly Fran L.³,Frankel Courtney³,Mebane Caroline M.¹,Ren Zhong¹,Bridgers Joshua¹,Urban Thomas J.⁶,Malone Colin D.¹,Finlen Copeland Ashley³,Brinkley Christie³,Allen Andrew S.⁷^ORCID,O’Riordan Thomas⁵,McHutchison John G.⁵,Palmer Scott M.³⁴,Goldstein David B.¹

Affiliation:

1. Institute for Genomic Medicine, Columbia University Medical Center, New York, New York

2. Department of Medicine, Austin Health and Royal Melbourne Hospital, The University of Melbourne, Melbourne, Victoria, Australia

3. Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Duke University Medical Center, Durham, North Carolina

4. Duke Clinical Research Institute, Durham, North Carolina

5. Gilead Sciences, Foster City, California

6. Division of Pharmacotherapy and Experimental Therapeutics, Center for Pharmacogenomics and Individualized Therapy, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina; and

7. Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Link

http://www.atsjournals.org/doi/pdf/10.1164/rccm.201610-2088OC

Reference37 articles.

1. An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management

2. Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001–11

3. Molecular Mechanisms in Progressive Idiopathic Pulmonary Fibrosis

4. A CommonMUC5BPromoter Polymorphism and Pulmonary Fibrosis

5. Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study

Cited by 192 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of telomere dysfunction and immune infiltration in idiopathic pulmonary fibrosis: new insights from bioinformatics analysis;Frontiers in Genetics;2024-09-13

2. Genetic architecture of telomere length in 462,666 UK Biobank whole-genome sequences;Nature Genetics;2024-08-27

3. Common and rare variant analyses reveal novel genetic factors underlying Idiopathic Pulmonary Fibrosis and shared aetiology with COVID-19;2024-08-17

4. Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision Medicine;American Journal of Respiratory and Critical Care Medicine;2024-08-15

5. Haploinsufficiency ofITSN1is associated with Parkinson’s disease;2024-07-27